Literature DB >> 21505955

A case of T cell prolymphocytic leukemia involving blast transformation.

Kunimoto Ichikawa1,2, Masaaki Noguchi3, Hidenori Imai3, Yasunobu Sekiguchi3, Mutsumi Wakabayashi3, Tomohiro Sawada4, Norio Komatsu5.   

Abstract

We report a case of T cell prolymphocytic leukemia (T-PLL) involving blast transformation. At the initial diagnosis, most peripheral blood cells demonstrated proliferation of indolent T cell small cell variants, i.e., small to medium prolymphocytes with inconspicuous nucleoli and a normal karyotype. These cells were positive for surface CD4, CD5, and CD7, and cytoplasmic CD3, but negative for surface CD3 and CD8 and cytoplasmic terminal deoxynucleotidyl transferase (TdT). The T cell receptor (TCR) Cβ1 gene was rearranged in the cells. Large prolymphocytes with prominent nucleoli, irregular nuclei, and cytoplasmic vacuoles that exhibited chromosome 8 trisomy were observed about 1.5 years later. The CD4+CD8- single positive effector memory T cells transformed into surface CD4+CD8+ double positive precursor T cells. The clonal TCR gene rearrangement patterns of these cells were identical throughout the clinical course, suggesting clonal blast transformation. The CD4+CD8+ cells demonstrated increased chromosome 8 trisomy combined with complex chromosome abnormalities with t(14;14)(q11.2;q32) containing a 14q32 chromosome after transformation. T cell leukemia 1a (TCL1a) (14q32.1) may be implicated in this case. The TCL1a oncoprotein is expressed in approximately 70% of T-PLL cases. The disease gradually developed resistance to chemotherapy, and the patient died of the disease. It is known that indolent T-PLL can become aggressive. Therefore, similar transformations may occur in other aggressive T-PLL cases, particularly those involving trisomy 8 and TCL1a.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505955     DOI: 10.1007/s12185-011-0826-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.

Authors:  E Matutes; V Brito-Babapulle; J Swansbury; J Ellis; R Morilla; C Dearden; A Sempere; D Catovsky
Journal:  Blood       Date:  1991-12-15       Impact factor: 22.113

Review 2.  T-cell prolymphocytic leukemia.

Authors:  Amit Khot; Claire Dearden
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

3.  Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.

Authors:  R Garand; J Goasguen; A Brizard; J Buisine; A Charpentier; J F Claisse; E Duchayne; M Lagrange; C Segonds; X Troussard; G Flandrin
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

Review 4.  True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.

Authors:  J D Hoyer; C W Ross; C Y Li; T E Witzig; R D Gascoyne; G W Dewald; C A Hanson
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

5.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.

Authors:  C E Dearden; E Matutes; B Cazin; G E Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; V Brito-Babapulle; M J Dyer; D Catovsky
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

Review 6.  B-CLL in PLL transformation associated with hypercalcemia.

Authors:  D Lerner; C Esteves; M S De Oliveira
Journal:  Leuk Lymphoma       Date:  1994-01

7.  Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia.

Authors:  M R el'Agnaf; K E Ennis; T C Morris; J H Robertson; G Markey; H D Alexander
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

8.  T cell prolymphocytic leukemia. 2 cases having a postthymic helper phenotype with complement receptors and 14q+ chromosome abnormality.

Authors:  D J Corwin; M E Kadin; T L Andres
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

9.  The morphological spectrum of T-prolymphocytic leukaemia.

Authors:  E Matutes; J Garcia Talavera; M O'Brien; D Catovsky
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

10.  T-cell prolymphocytic leukaemia: a clinical and immunological study.

Authors:  F Lauria; R Foa; D Raspadori; M R Motta; P L Tazzari; G Biagini; P Preda; R Algeri; S Tura
Journal:  Scand J Haematol       Date:  1985-09
View more
  1 in total

1.  T-cell prolymphocytic leukemia in Japan: is it a variant?

Authors:  Junichi Kameoka; Naoto Takahashi; Hideyoshi Noji; Kazunori Murai; Katsushi Tajima; Yoshihiro Kameoka; Shinji Sato; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-04-24       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.